Journal
JOURNAL OF AUTISM AND DEVELOPMENTAL DISORDERS
Volume 47, Issue 7, Pages 2217-2224Publisher
SPRINGER/PLENUM PUBLISHERS
DOI: 10.1007/s10803-017-3148-7
Keywords
Autism spectrum disorder; Attention-deficit hyperactivity disorder; Internet addiction; Behavioral addiction
Categories
Funding
- Nippon Hyoron Sha Co., Ltd.
- Nanzando Co., Ltd.
- Seiwa Shoten Co., Ltd.
- Igaku-shoin Ltd.
- Technomics, Inc.
- Japanese Ministry of Health, Labour and Welfare
- Japanese Ministry of Education, Science, and Technology
- Eisai Co., Ltd.
- Mochida Pharmaceutical Co., Ltd.
- Astellas Pharma Inc.
- Otsuka Pharmaceutical Co., Ltd.
- GlaxoSmithKline K. K.
- Shionogi Co.
- Sumitomo Dainippon Pharma Co., Ltd.
- Jansen Pharmaceutical K. K.
- Pfizer Japan Inc.
- MSD K. K.
- Yoshitomiyakuhin Corporation
- Daiichi Sankyo Co. Ltd.
- Meiji Seika Pharma Co., Ltd.
- Tsumura Co.
- AbbVie
- Ono Pharmaceutical Co., Ltd.
- Eli Lilly Japan K. K.
Ask authors/readers for more resources
Extant literature suggests that autism spectrum disorder (ASD) and attention-deficit hyperactivity disorder (ADHD) are risk factors for internet addiction (IA). The present cross-sectional study explored the prevalence of IA among 132 adolescents with ASD and/or ADHD in a Japanese psychiatric clinic using Young's Internet Addiction Test. The prevalence of IA among adolescents with ASD alone, with ADHD alone and with comorbid ASD and ADHD were 10.8, 12.5, and 20.0%, respectively. Our results emphasize the clinical importance of screening and intervention for IA when mental health professionals see adolescents with ASD and/or ADHD in psychiatric services.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available